IL110158A - (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine and pharmaceutical compositions containing them - Google Patents

(1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine and pharmaceutical compositions containing them

Info

Publication number
IL110158A
IL110158A IL11015894A IL11015894A IL110158A IL 110158 A IL110158 A IL 110158A IL 11015894 A IL11015894 A IL 11015894A IL 11015894 A IL11015894 A IL 11015894A IL 110158 A IL110158 A IL 110158A
Authority
IL
Israel
Prior art keywords
heterocyclyl
phenyl
methylamine
methanol
pharmaceutical compositions
Prior art date
Application number
IL11015894A
Other languages
English (en)
Other versions
IL110158A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302334A external-priority patent/SE9302334D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL110158A0 publication Critical patent/IL110158A0/xx
Publication of IL110158A publication Critical patent/IL110158A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11015894A 1993-07-06 1994-06-29 (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine and pharmaceutical compositions containing them IL110158A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9302334A SE9302334D0 (sv) 1993-07-06 1993-07-06 New compounds
US08/379,469 US5712299A (en) 1993-07-03 1994-07-05 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives
US45663795A 1995-06-02 1995-06-02

Publications (2)

Publication Number Publication Date
IL110158A0 IL110158A0 (en) 1994-10-07
IL110158A true IL110158A (en) 1999-07-14

Family

ID=27355726

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11015894A IL110158A (en) 1993-07-06 1994-06-29 (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5712299A (cs)
EP (1) EP0707574A1 (cs)
JP (1) JPH08512314A (cs)
CN (1) CN1047169C (cs)
AU (1) AU691821B2 (cs)
BR (1) BR9406925A (cs)
CA (1) CA2164960A1 (cs)
CZ (1) CZ4296A3 (cs)
FI (1) FI960078A7 (cs)
HU (1) HUT74671A (cs)
IL (1) IL110158A (cs)
MX (1) MX9405111A (cs)
NO (1) NO305953B1 (cs)
NZ (1) NZ268691A (cs)
PL (1) PL179015B1 (cs)
SG (1) SG48081A1 (cs)
SK (1) SK160095A3 (cs)
WO (1) WO1995001968A1 (cs)
ZA (1) ZA944647B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0758323A1 (en) * 1994-05-02 1997-02-19 Zeneca Limited Herbicidal hydroxybenzyl-substituted heteroaryl compounds and derivatives thereof
US6573289B1 (en) 1998-04-23 2003-06-03 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
EA200300379A1 (ru) 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
GB0711776D0 (en) * 2007-06-18 2007-07-25 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
US8957086B2 (en) 2010-05-05 2015-02-17 The Board Of Trustees Of The University Of Illinois Compounds and methods of treating brain disorders
US9150527B2 (en) 2011-08-30 2015-10-06 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN103214396B (zh) * 2013-04-10 2015-01-21 湖北工业大学 3-氰基苯甲酸的生产方法
CN103193658A (zh) * 2013-04-18 2013-07-10 苏州永健生物医药有限公司 一种（r）-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法

Also Published As

Publication number Publication date
NO960030L (no) 1996-01-04
HU9503743D0 (en) 1996-02-28
NZ268691A (en) 1997-09-22
NO305953B1 (no) 1999-08-23
SK160095A3 (en) 1997-06-04
EP0707574A1 (en) 1996-04-24
US5712299A (en) 1998-01-27
FI960078A0 (fi) 1996-01-08
PL312428A1 (en) 1996-04-29
WO1995001968A1 (en) 1995-01-19
AU7197994A (en) 1995-02-06
MX9405111A (es) 1995-01-31
JPH08512314A (ja) 1996-12-24
HUT74671A (en) 1997-01-28
NO960030D0 (no) 1996-01-04
SG48081A1 (en) 1998-04-17
PL179015B1 (pl) 2000-07-31
BR9406925A (pt) 1996-07-30
CN1126991A (zh) 1996-07-17
CZ4296A3 (en) 1996-06-12
ZA944647B (en) 1995-01-06
AU691821B2 (en) 1998-05-28
FI960078A7 (fi) 1996-01-08
IL110158A0 (en) 1994-10-07
CA2164960A1 (en) 1995-01-19
CN1047169C (zh) 1999-12-08

Similar Documents

Publication Publication Date Title
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
HU9402974D0 (en) Pharmaceutical composition
GB9317686D0 (en) Pharmaceutical compositions
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
GB9317610D0 (en) Pharmaceutical compositions
ZA945930B (en) Pharmaceutical composition
IL110809A0 (en) 1,5-diphenyl-3-pyrazolylalkyl-n-hydroxydithiocarbamates and pharmaceutical compositions containing them
IL110158A0 (en) (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine and pharmaceutical compositions containing them
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (en) Pharmaceutical composition
GB9317504D0 (en) Pharmaceutical compositions
ZA945752B (en) Pharmaceutical composition
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
GB9318880D0 (en) Pharmaceutical composition
IL106352A0 (en) Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them
IL119412A0 (en) Gonadotropins and pharmaceutical compositions containing them
GB9420129D0 (en) Pharmaceutical compositions
LTIP1528A (en) Novel peptides and pharmaceutical compositions containing them
GB9214489D0 (en) Pharmaceutical compositions and uses therefor
HU9603341D0 (en) Novel glucosides as blood-clotting-inhibitors and pharmaceutical compositions containing them
GB9417021D0 (en) Pharmaceutical composition
ZA947913B (en) Pharmaceutical composition
GB9320688D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees